Influenza viral load and peramivir kinetics after single administration and proposal of regimens for peramivir administration against resistant variants - Wikidata - awgldk - TriplyDB

Influenza viral load and peramivir kinetics after single administration and proposal of regimens for peramivir administration against resistant variants

Influenza viral load and peramivir kinetics after single administration and proposal of regimens for peramivir administration against resistant variants

http://www.wikidata.org/entity/Q35076812

about

Peramivir injection in the treatment of acute influenza: a review of the literature Japanese Surveillance Systems and Treatment for Influenza.Influenza A H1N1 pdm09-associated myocarditis during zanamivir therapy.

P2860

Q28068310-1B6FC407-EF47-4682-824E-B8C65D3EE081 Q30239895-D6503CB0-6B14-4A13-A9A6-EA5033EB0517 Q51582267-6C9902CB-4656-4042-A2D4-68C2F02B713D

P2860

Influenza viral load and peramivir kinetics after single administration and proposal of regimens for peramivir administration against resistant variants

http://www.wikidata.org/entity/Q35076812

description

2014 nî lūn-bûn

@nan

2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Influenza viral load and peram ...... ion against resistant variants

@ast

Influenza viral load and peram ...... ion against resistant variants

@en

type

label

Influenza viral load and peram ...... ion against resistant variants

@ast

Influenza viral load and peram ...... ion against resistant variants

@en

prefLabel

Influenza viral load and peram ...... ion against resistant variants

@ast

Influenza viral load and peram ...... ion against resistant variants

@en

P1433

Q35076812-08E55619-EBBA-41C9-9734-C9ED8C3C6369

P1476

Q35076812-2C01F9ED-0475-4DD4-A2E5-9ED2FEDFEE84

P2093

Q35076812-2FA7E90F-0A42-4E94-ACEA-3A79B4487AE8

Q35076812-3968ABE4-1A8D-42EB-8909-49F72D3B1509

Q35076812-3AF8D619-AE83-4D0E-BFF5-A46881022391

Q35076812-3F88DDCF-9D40-4FA0-8F50-ACEF77E7BDBB

Q35076812-4E802958-1941-4622-A0BF-196E7D76323A

Q35076812-600E8696-959B-4F55-AF23-B1C27EA9F0FC

Q35076812-7EF9E5D2-DBB7-40B8-B311-4C78310A43E2

Q35076812-82BC5524-7AB6-4DE3-9FB7-319E59AA53B1

Q35076812-8A1A0016-E501-438A-85CC-17ECDAA29B3F

Q35076812-C3AE810D-8119-4217-9F81-7316EB630D73

P2860

Q35076812-02F0E440-C46C-4765-B4A2-61F29C5B1ED8

Q35076812-20E9CEFA-6A4B-4F55-BFB5-99E3DAB6B9FB

Q35076812-29A60698-4A27-4187-BD11-45C9B02D3931

Q35076812-3294EF81-8529-4AD5-9C6C-B9F2151A448B

Q35076812-38FD9143-30B2-44FB-BF97-D2D55E0BE8DA

Q35076812-50988CC0-0F63-457D-9AEE-8FA4AEAA0D20

Q35076812-5D5F5A9D-07C3-4795-A53B-1F8621D330C6

Q35076812-60735E86-6A99-4829-A876-86FCC68EA1F1

Q35076812-66DFB2C9-8DCB-4433-AD1C-925A1640C192

Q35076812-79F5F9A2-0019-4EF8-B622-51ED0DCD56FA

P304

Q35076812-76011F9B-6A93-4CF5-86C4-153E4EB0851A

P31

Q35076812-3190105E-3A66-4D36-9569-64184CEC1FF4

P356

Q35076812-76C1198C-1CC4-4E4A-8BF7-B074CBFA66D5

P407

Q35076812-94F512E0-BD41-4D84-94C9-6C196F7029B6

P433

Q35076812-4B267F64-2A45-419E-B228-1B6A23C7E4EE

P478

Q35076812-81DD1D08-7E06-4C6B-9D4A-54AD12807593

P577

Q35076812-AFD37524-4696-4372-994C-AEBF22A84DD7

P698

Q35076812-B054D4E6-3253-4A21-A426-64EC0C6D1AEE

P921

Q35076812-21739C11-6C82-4254-B8E3-55B029C45143

Q35076812-8407A1CC-35E6-4A11-A027-5B54A77D4F58

Q35076812-98B942E0-9342-4196-9680-D5AF4D63021D

P932

Q35076812-C9AFF262-9FFF-466A-BEB2-C8F73AE1C7D0

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Influenza viral load and peram ...... ion against resistant variants

@en

P2093

Aya Takeyama

http://www.w3.org/2001/XMLSchema#string

Hiroko Sakuma

http://www.w3.org/2001/XMLSchema#string

Koichi Hashimoto

http://www.w3.org/2001/XMLSchema#string

Kyohei Miyazaki

http://www.w3.org/2001/XMLSchema#string

Masahiro Watanabe

http://www.w3.org/2001/XMLSchema#string

Masaki Ito

http://www.w3.org/2001/XMLSchema#string

Masatoki Sato

http://www.w3.org/2001/XMLSchema#string

Mitsuaki Hosoya

http://www.w3.org/2001/XMLSchema#string

Shigeo Suzuki

http://www.w3.org/2001/XMLSchema#string

Shinichi Oda

http://www.w3.org/2001/XMLSchema#string

P2860

Structural studies of the resistance of influenza virus neuramindase to inhibitors

Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection.

Analytical performance determination and clinical validation of the novel Roche RealTime Ready Influenza A/H1N1 Detection Set.

Early emergence of an H275Y mutation in a hematopoietic cell transplant recipient treated with intravenous peramivir.

Efficacy, safety, and pharmacokinetics of intravenous peramivir in children with 2009 pandemic H1N1 influenza A virus infection

Oseltamivir-resistant pandemic (H1N1) 2009 virus infections, United States, 2010-11.

Oral oseltamivir treatment of influenza in children.

Clinical findings in 111 cases of influenza A (H7N9) virus infection.

Pharmacodynamic evaluation of RWJ-270201, a novel neuraminidase inhibitor, in a lethal murine model of influenza predicts efficacy for once-daily dosing.

Drug susceptibility surveillance of influenza viruses circulating in the United States in 2011-2012: application of the WHO antiviral working group criteria.

P304

1643-1649

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.04263-14

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

59

http://www.w3.org/2001/XMLSchema#string

P577

2014-12-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25547357

http://www.w3.org/2001/XMLSchema#string

P921

peramivir tetrahydrate

P932

4325767

http://www.w3.org/2001/XMLSchema#string